MARPAI REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Get Alerts MRAI Hot Sheet
Join SI Premium – FREE
Reduces Operating Expense by over
Q1 2024 Financial Highlights:
- Net revenues were approximately
$7.4 million for the three months endedMarch 31, 2024 , down$2.3 million , or 24% lower year over year, compared to the three months endedMarch 31, 2023 . - Gross profit was
$2.5 million for the three months endedMarch 31, 2024 , down$0.7 million , or 23% lower year over year compared to the three months endedMarch 31, 2023 . - Operating expenses were
$6.6 million for the three months endedMarch 31, 2024 , an improvement of$5.2 million , or 44% lower year over year compared to the three months endedMarch 31, 2023 . - Operating loss was
$4.1 million for the three months endedMarch 31, 2024 , an improvement of$4.5 million , or 52% lower year over year compared to the three months endedMarch 31, 2023 . - Net loss was
$4.3 million for the three months endedMarch 31, 2024 , an improvement of$4.5 million , or 51% lower year over year compared to the three months endedMarch 31, 2023 . - Basic and diluted earnings per share were (
$0.46 ) for the three months endedMarch 31, 2024 , an improvement of$1.22 per share year over year compared to the three months endedMarch 31, 2023 .
"The market is evolving, and we're adapting our approach to better serve our clients' needs. While we saw some client turnover in the first quarter, we are confident that our new initiatives will lead to long-term revenue growth and profitability," said
Webcast and Conference Call Information
Marpai expects to host a conference call and webcast on
Investors interested in listening to the conference call may do so by dialing (800)-836-8184 for domestic callers or +1-646-357-8785 for international callers, or via webcast: https://app.webinar.net/MVqDW74kNpl
About Marpai, Inc.
Marpai, Inc. (Nasdaq: MRAI) is a leading, national TPA company bringing value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the
Forward-Looking Statement Disclaimer
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses that it is confident that its new initiatives will lead to long-term revenue growth and profitability and that its additional cost-reduction program is expected to generate
More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.
MARPAI, INC. AND SUBSIDIARIES | ||||
CONDENSED CONSOLIDATED BALANCE SHEET | ||||
(in thousands, except share and per share data) | ||||
(Unaudited) | ||||
ASSETS: | ||||
Current assets: | ||||
Cash and cash equivalents | $ 851 | $ 1,147 | ||
Restricted cash | 12,761 | 12,345 | ||
Accounts receivable, net of allowance for credit losses of | 366 | 1,124 | ||
Unbilled receivable | 727 | 768 | ||
Due from buyer for sale of business unit | 800 | 800 | ||
Prepaid expenses and other current assets | 1,000 | 901 | ||
Total current assets | 16,505 | 17,085 | ||
Property and equipment, net | 579 | 611 | ||
Capitalized software, net | 1,512 | 2,127 | ||
Operating lease right-of-use assets | 2,311 | 2,373 | ||
Goodwill | 3,018 | 3,018 | ||
Intangible assets, net | 4,874 | 5,177 | ||
Security deposits | 1,267 | 1,267 | ||
Other long-term asset | 22 | 22 | ||
Total assets | $ 30,088 | $ 31,680 | ||
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | ||||
Current liabilities: | ||||
Accounts payable | $ 3,824 | $ 4,649 | ||
Accrued expenses | 3,076 | 2,816 | ||
Accrued fiduciary obligations | 9,510 | 11,573 | ||
Deferred revenue | 1,481 | 661 | ||
Current portion of operating lease liabilities | 523 | 512 | ||
Other short-term liabilities | 1,709 | 632 | ||
Total current liabilities | 20,123 | 20,843 | ||
Other long-term liabilities | 19,724 | 19,401 | ||
Operating lease liabilities, net of current portion | 3,547 | 3,684 | ||
Deferred tax liabilities | 1,190 | 1,190 | ||
Total liabilities | 44,584 | 45,118 | ||
COMMITMENTS AND CONTINGENCIES | ||||
STOCKHOLDERS' (DEFICIT) EQUITY | ||||
Common stock, | 1 | 1 | ||
Additional paid-in capital | 66,595 | 63,307 | ||
Accumulated deficit | (81,092) | (76,746) | ||
Total stockholders' (deficit) equity | (14,496) | (13,438) | ||
Total liabilities and stockholders' (deficit) equity | $ 30,088 | $ 31,680 | ||
(1) Reflects 1-for-4 reverse stock split that became effective |
MARPAI, INC. AND SUBSIDIARIES | ||||
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS | ||||
(in thousands, except share and per share data) | ||||
(Unaudited) | ||||
Three Months Ended | ||||
Revenue | $ 7,385 | $ 9,672 | ||
Costs and expenses | ||||
Cost of revenue (exclusive of depreciation and amortization | 4,871 | 6,409 | ||
General and administrative | 3,421 | 5,226 | ||
Sales and marketing | 602 | 2,179 | ||
Information technology | 1,124 | 2,187 | ||
Research and development | 7 | 500 | ||
Depreciation and amortization | 951 | 1,044 | ||
Facilities | 474 | 650 | ||
Total costs and expenses | 11,450 | 18,195 | ||
Operating loss | (4,065) | (8,523) | ||
Other income (expenses) | ||||
Other income | 120 | 50 | ||
Interest expense, net | (398) | (385) | ||
Foreign exchange (loss) gain | (3) | (15) | ||
Loss before provision for income taxes | (4,346) | (8,873) | ||
Income tax expense | — | — | ||
Net loss | $ (4,346) | $ (8,873) | ||
Net loss per share, basic & fully diluted (1) | $ (0.46) | $ (1.68) | ||
Weighted average common shares outstanding, basic and | 9,405,775 | 5,290,661 | ||
(1) Reflects 1-for-4 reverse stock split that became effective |
MARPAI, INC. AND SUBSIDIARIES | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(in thousands, except share and per share data) | ||||
(Unaudited) | ||||
Three Months Ended | ||||
Cash flows from operating activities: | ||||
Net loss | $ (4,346) | $ (8,873) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
Depreciation and amortization | 951 | 1,044 | ||
Share-based compensation | 561 | 623 | ||
Common stock issued to vendors in exchange for services | — | 79 | ||
Amortization of right-of-use asset | 62 | 252 | ||
Non-cash interest | 423 | 388 | ||
Changes in operating assets and liabilities: | ||||
Accounts receivable and unbilled receivable | 800 | (239) | ||
Prepaid expense and other assets | (99) | 162 | ||
Accounts payable | (825) | 653 | ||
Accrued expenses | 215 | (1,416) | ||
Accrued fiduciary obligations | (2,063) | — | ||
Operating lease liabilities | (126) | (363) | ||
Other liabilities | 862 | 1,149 | ||
Net cash used in operating activities | (3,585) | (6,541) | ||
Cash flows from investing activities: | ||||
Disposal of property and equipment | — | 3 | ||
Net cash provided by investing activities | — | 3 | ||
Cash flows from financing activities: | ||||
Proceeds from sale of future cash receipts on accounts receivable | 1,509 | — | ||
Payments to buyer of receivables | (57) | — | ||
Payments to seller for acquisition | (474) | — | ||
Proceeds from issuance of common stock in a public offering, net | 2,727 | — | ||
Net cash provided by financing activities | 3,705 | — | ||
Net increase (decrease) in cash, cash equivalents and restricted cash | 120 | (6,538) | ||
Cash, cash equivalents and restricted cash at beginning of period | 13,492 | 23,117 | ||
Cash, cash equivalents and restricted cash at end of period | $ 13,612 | $ 16,579 | ||
Reconciliation of cash, cash equivalents, and restricted cash reported in | ||||
Cash and cash equivalents | $ 851 | $ 6,174 | ||
Restricted cash | 12,761 | 10,405 | ||
Total cash, cash equivalents and restricted cash shown in the condensed | $ 13,612 | $ 16,579 | ||
Supplemental disclosure of non-cash activity | ||||
Measurement period adjustment to Goodwill | $ — | $ 36 | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-reports-first-quarter-2024-financial-results-302141613.html
SOURCE Marpai
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Cosmos Health signs Qatar distribution deal, gets 31,000-unit order
- Spyre Therapeutics (SYRE) files mixed shelf
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share